News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Tanios S. Bekaii-Saab, MD

Advertisement

Articles by Tanios S. Bekaii-Saab, MD

All Patients With GI Cancers Should Undergo NGS

ByTanios S. Bekaii-Saab, MD
February 13th 2020

The results of genetic testing could change a patient's treatment regimen.

Advertisement

Latest Updated Articles

  • All Patients With GI Cancers Should Undergo NGS
    All Patients With GI Cancers Should Undergo NGS

    Published: February 13th 2020 | Updated:



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves TTFields Device With Chemo in Pancreatic Cancer

2

Understanding the Pembrolizumab Treatment Combo in Platinum-Resistant Ovarian Cancers

3

Advancing NSCLC Care: RMAT Status, Treatment Timing, and ASCO Updates

4

Improving Patient Adherence Through Integrative Oncology Care

5

FDA Approves Pembrolizumab Combination in Platinum-Resistant Ovarian Cancer

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us